← Open Payments lookup

ABIGAIL MITZEL: Open Payments

NPI 1548037617 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,921 in 95 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $1,410 · 2025 $1,921

Food & beverage: $1,921
CompanyPaymentsAmount
ABBVIE INC.39$672
Madrigal Pharmaceuticals7$262
QOL Medical, LLC11$245
Takeda Pharmaceuticals U.S.A., Inc.5$107
Janssen Biotech, Inc.6$97
Aimmune Therapeutics, Inc.5$95
Gilead Sciences, Inc.3$88
GENZYME CORPORATION3$69
E.R. Squibb & Sons, L.L.C.2$55
Novo Nordisk Inc1$40

Products named: RINVOQ, REZDIFFRA, Sucraid, SKYRIZI, LINZESS, ENTYVIO, TREMFYA, ZENPEP.

Industry payments across NV — which companies pay providers there.